Mirion Technologies, Inc. (MIR)
| Market Cap | 4.18B -26.7% |
| Revenue (ttm) | 1.08B +19.7% |
| Net Income | 29.00M +9.4% |
| EPS | 0.11 +9.1% |
| Shares Out | 245.49M |
| PE Ratio | 159.00 |
| Forward PE | 27.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,936,860 |
| Open | 17.30 |
| Previous Close | 17.74 |
| Day's Range | 17.03 - 17.76 |
| 52-Week Range | 14.04 - 27.49 |
| Beta | 1.07 |
| Analysts | Strong Buy |
| Price Target | 23.18 (+36.03%) |
| Earnings Date | Oct 27, 2026 |
About MIR
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medi... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for MIR stock is "Strong Buy." The 12-month stock price target is $23.18, which is an increase of 36.03% from the latest price.
News
Existing Nuclear Fleet Upgrades Drive Investment Momentum
Extending the lifespans of current reactors creates compelling opportunities across the broader nuclear energy supply chain. While advanced reactor designs often capture headlines, the existing nuclea...
Mirion Technologies Transcript: Baird 2026 Global Industrial Conference
Installed-base nuclear demand is accelerating, with management seeing a decade or more of spending growth and broad opportunities in plant upgrades and new builds. Medical trends are improving, while margin accretion is expected to run at ~1 point annually or better, with updated guidance planned for early 2027.
Mirion to Present at Baird's 2026 Global Industrial Conference
ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will pres...
Mirion price target lowered to $25 from $27 at B. Riley
B. Riley lowered the firm’s price target on Mirion (MIR) to $25 from $27 and keeps a Buy rating on the shares. Mirion raised revenue growth guidance but lowered EBITDA…
Mirion Technologies Earnings Call Transcript: Q3 2026
Q3 orders and backlog surged, supporting raised FY organic revenue and cash flow guidance and expected mid- to high-teens Q4 organic growth. Margin pressure, front-loaded AI spending, and slower Medical growth temper the outlook, while nuclear fleet investment is a major demand driver.
Mirion Technologies Earnings release: Q3 2026
Mirion Technologies released its Q3 2026 earnings on October 28, 2026, summarizing the period's financial results.
Mirion Technologies Slides: Q3 2026
Mirion Technologies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 28, 2026.
Mirion Technologies Quarterly report: Q3 2026
Mirion Technologies has published its Q3 2026 quarterly earnings report on October 28, 2026.
Mirion Announces Third Quarter 2026 Financial Results
ATLANTA--(BUSINESS WIRE)--Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and re...
Mirion Extends Support of IAEA Mission to Advance Cancer Care Globally through Rays of Hope Donation
ATLANTA--(BUSINESS WIRE)--Mirion, a leading provider of advanced radiation safety solutions, has announced support for the International Atomic Energy Agency (IAEA) Rays of Hope initiative, which aims...
Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2026
ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for third quarter 2026 after market close on Tuesday, October 27, 2026. Following the news release, ...
Mirion price target lowered to $20 from $23 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Mirion (MIR) to $20 from $23 and keeps a Buy rating on the shares.
Mirion Technologies to Host Inaugural Mirion Connect EMEA/APAC Conference in Brussels
BRUSSELS--(BUSINESS WIRE)--Mirion Technologies, a leading provider of advanced radiation safety solutions, today announced Mirion Connect 2026 EMEA/APAC, the company's first regional edition of its Mi...
Mirion added to ‘Positive Catalyst Watch’ at JPMorgan
JPMorgan added a “Positive Catalyst Watch” on shares of Mirion (MIR) while keeping an Overweight rating on the shares with a $22 price target The company’s backlog conversion and “steadier”…
Mirion initiated with a Buy at Jefferies
Jefferies initiated coverage of Mirion (MIR) with a Buy rating and $20 price target Mirion is one of the most direct ways to gain exposure to accelerating nuclear investment, the…
Mirion CFO buys $312K in common stock
In a regulatory filing Mirion (MIR) discloses that its CFO, Brian Schopfer, buys 20K shares of common stock on September 2nd in a total transaction size of $312K. Shares are…
Mirion announces new $250M buyback program
The company states: “On August 31, the Board of Directors of Mirion (MIR) Technologies, Inc. approved a new share repurchase program authorizing the repurchase of up to $250 million of…
Mirion price target lowered to $23 from $25 at Morgan Stanley
Morgan Stanley analyst Christopher Snyder lowered the firm’s price target on Mirion (MIR) to $23 from $25 and keeps an Equal Weight rating on the shares.
Mirion price target lowered to $22 from $27 at JPMorgan
JPMorgan lowered the firm’s price target on Mirion (MIR) to $22 from $27 and keeps an Overweight rating on the shares.
Mirion price target lowered to $24 from $29 at Northland
Northland analyst Jeff Grampp lowered the firm’s price target on Mirion (MIR) to $24 from $29 and keeps an Outperform rating on the shares. Shares traded down 13% yesterday on…
Mirion price target lowered to $27 from $29 at B. Riley
B. Riley analyst Yuan Zhi lowered the firm’s price target on Mirion (MIR) to $27 from $29 and keeps a Buy rating on the shares. Mirion delivered an in-line Q2…
Mirion price target lowered to $22 from $26 at Baird
Baird lowered the firm’s price target on Mirion (MIR) to $22 from $26 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results as…
Mirion price target lowered to $24 from $28 at Citi
Citi analyst Andrew Kaplowitz lowered the firm’s price target on Mirion (MIR) to $24 from $28 and keeps a Buy rating on the shares.
Mirion price target lowered to $23 from $25 at Goldman Sachs
Goldman Sachs lowered the firm’s price target on Mirion (MIR) to $23 from $25 and keeps a Buy rating on the shares after its Q2 results. This will be a…